🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/06/2003 | 59,06 | 59,36 | 58,29 | 58,38 | -1,56% | 1,81% | 5.014.785 |
| 24/06/2003 | 58,44 | 59,69 | 58,43 | 59,30 | +0,06% | 2,17% | 6.449.706 |
| 23/06/2003 | 59,59 | 59,78 | 58,71 | 59,27 | -1,24% | 1,79% | 5.496.760 |
| 20/06/2003 | 59,45 | 60,35 | 59,35 | 60,01 | +0,95% | 1,69% | 7.822.167 |
| 19/06/2003 | 60,34 | 60,59 | 59,17 | 59,45 | -1,49% | 2,36% | 6.886.198 |
| 18/06/2003 | 59,33 | 60,55 | 59,00 | 60,34 | +1,39% | 2,62% | 13.435.779 |
| 17/06/2003 | 58,41 | 60,50 | 58,30 | 59,51 | +2,58% | 3,76% | 12.434.730 |
| 16/06/2003 | 56,52 | 58,51 | 56,50 | 58,02 | +2,65% | 3,56% | 11.450.029 |
| 13/06/2003 | 56,59 | 56,92 | 55,87 | 56,52 | -0,12% | 1,85% | 5.798.374 |
| 12/06/2003 | 56,77 | 57,01 | 56,19 | 56,58 | -0,05% | 1,45% | 5.093.280 |
| 11/06/2003 | 55,88 | 57,02 | 55,87 | 56,61 | +1,51% | 2,07% | 5.568.443 |
| 10/06/2003 | 55,61 | 55,92 | 54,96 | 55,77 | +0,26% | 1,72% | 4.363.662 |
| 09/06/2003 | 56,25 | 56,49 | 55,30 | 55,63 | -1,29% | 2,12% | 4.017.089 |
| 06/06/2003 | 56,52 | 57,50 | 55,82 | 56,36 | +0,53% | 2,97% | 8.809.174 |
| 05/06/2003 | 54,18 | 56,06 | 53,91 | 56,06 | +3,34% | 3,96% | 8.090.665 |
| 04/06/2003 | 53,61 | 54,50 | 53,39 | 54,25 | +0,98% | 2,08% | 5.130.379 |
| 03/06/2003 | 53,42 | 54,05 | 53,20 | 53,72 | +1,02% | 1,59% | 6.275.634 |
| 02/06/2003 | 53,24 | 53,75 | 53,08 | 53,18 | +0,27% | 1,25% | 6.622.941 |
| 30/05/2003 | 52,39 | 53,24 | 52,39 | 53,03 | +1,50% | 1,64% | 6.675.341 |
| 29/05/2003 | 53,19 | 53,80 | 52,15 | 52,25 | -1,76% | 3,10% | 7.721.874 |
| 28/05/2003 | 53,58 | 53,76 | 52,80 | 53,19 | -1,06% | 1,80% | 8.050.526 |
| 27/05/2003 | 52,65 | 53,93 | 52,24 | 53,76 | +1,60% | 3,21% | 7.178.800 |
| 23/05/2003 | 53,20 | 53,59 | 52,62 | 52,91 | -0,18% | 1,81% | 4.223.335 |
| 22/05/2003 | 52,62 | 53,49 | 52,39 | 53,01 | +0,31% | 2,10% | 6.705.209 |
| 21/05/2003 | 52,39 | 53,15 | 51,92 | 52,84 | +0,71% | 2,35% | 11.662.249 |
| 20/05/2003 | 53,53 | 53,70 | 51,62 | 52,47 | -2,93% | 3,89% | 14.915.660 |
| 19/05/2003 | 56,11 | 56,49 | 53,05 | 54,06 | -4,71% | 6,12% | 14.648.420 |
| 16/05/2003 | 56,52 | 56,92 | 56,11 | 56,73 | -0,13% | 1,43% | 4.419.311 |
| 15/05/2003 | 56,88 | 57,03 | 56,41 | 56,80 | -0,15% | 1,09% | 4.736.331 |
| 14/05/2003 | 56,87 | 57,14 | 56,39 | 56,89 | +0,49% | 1,31% | 5.186.552 |